C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
基本信息
- 批准号:10493960
- 负责人:
- 金额:$ 57.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2027-05-31
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAddressAdoptionAdvisory CommitteesCessation of lifeClimateCocaineCollaborationsComputerized Medical RecordDataData CollectionDissemination and ImplementationDropsEffectivenessEnsureEvaluationEvidence based interventionEvidence based treatmentExcisionFamilyFeedbackGoalsHIV InfectionsHuman ResourcesIncentivesIndividualInterviewLaboratoriesLeadershipLegalMaintenanceMeasuresMediator of activation proteinMedicalMentorsMethamphetamineMethodsModelingNew EnglandOpioidOutcomeOverdosePatient-Focused OutcomesPatientsPerceptionPerformancePersonsPharmaceutical PreparationsPhasePopulationProviderPublic HealthPublic SectorQuality of CareRandomizedReach Effectiveness Adoption Implementation and MaintenanceReportingResearchResearch Project GrantsRiskRoleScienceService provisionServicesSourceSpecific qualifier valueStimulantTechnology TransferTestingTimeTrainingUnited States Substance Abuse and Mental Health Services Administrationaddictioncohortcontextual factorscontingency managementdata harmonizationdesigneffective interventioneffectiveness implementation studyeffectiveness implementation trialeffectiveness testingevidence baseexperienceexperimental studyfollow up assessmentfollow-uphigh riskimplementation contextimplementation determinantsimplementation outcomesimplementation scienceimplementation strategyimprovedmedical specialtiesopioid epidemicopioid overdoseopioid treatment programopioid useopioid use disorderoverdose deathpsychostimulantrecruitresearch to practicestandardize measurestimulant dependencestimulant usetreatment durationtreatment organizationtreatment responsetreatment servicesuptake
项目摘要
C-DIAS RESEARCH PROJECT 2: PROJECT SUMMARY/ABSTRACT
This rigorous experiment addresses a critical public health problem--the rising stimulant/opioid epidemic. It
advances implementation science through the evaluation of a multi-level implementation strategy and specifies
of contextual determinants of outcomes. Stimulants constitute a new and deadly fourth wave of the opioid
epidemic. Among persons with opioid use disorder, stimulant use has been associated with more persistent
opioid use; higher risk of HIV infection; higher levels of family, medical, legal, and vocational problems; and
higher risk of lethal overdose. Contingency management (CM) is the most effective intervention for stimulant
use and is an evidence-based adjunct to medication for opioid use disorder (MOUD). Yet, uptake of CM in
opioid treatment programs (OTPs) that provide MOUD remains low: in fact, access to CM is arguably one of
the greatest research-to-practice gaps in the addiction treatment services field. The goal of C-DIAS Research
Project 2 is to conduct a type III hybrid effectiveness-implementation trial to evaluate a multi-level
implementation strategy, the Science to Service Laboratory (SSL), to install CM for stimulant use in OTPs. The
SSL has three core components: didactic training; performance feedback; and external facilitation. The project
employs common C-DIAS frameworks, measures, and methods to guide SSL evaluation. Utilizing a stepped
wedge design, a regional cohort of 10 public sector OTPs will be randomized to receive SSL at five distinct
time points. At six intervals, each of the 10 OTPs will provide data from all available patient charts on CM
delivery and patient outcomes. Each OTP will also recruit 10 patients per wedge (n = 500 patients) to complete
a baseline interview and 3-month follow-up. In addition, staff from each OTP will report on contextual
determinants of implementation outcomes at three timepoints. This study will rigorously evaluate whether a
multi-level implementation strategy developed by one of the longest-standing national intermediary purveyor
organizations--the SAMHSA Technology Transfer Centers, will improve both implementation and patient
outcomes. Implementation outcomes are guided by RE-AIM and include CM Reach, Adoption, Implementation
and Sustainment, while patient outcomes include measures of CM Effectiveness such as stimulant abstinence
and treatment retention. The study will advance the C-DIAS scientific aims by unpacking the black box of
implementation strategies and exploring the mediational and moderating influence of context on
implementation outcomes. Focused on the active IMPLEMENT phase, this Research Project leverages a bi-
directional synergistic relationship with C-DIAS. Some but not all examples of this include: 1) standardized
measures of implementation context, outcomes and procedural details of strategies; 2) PI (Becker)’s role on
the C-DIAS Research Core; 3) a close network of collaboration and mentoring among the key project
personnel and C-DIAS PI; and 4) harmonization of data that can be used for modeling by C-DIAS Research
Core experts.
C-DIAS 研究项目 2:项目摘要/摘要
这项严格的实验解决了一个关键的公共卫生问题——兴奋剂/阿片类药物的流行。
通过评估多层次实施战略来推进实施科学,并指定
兴奋剂构成了新的致命的第四波阿片类药物。
在患有阿片类药物使用障碍的人中,兴奋剂的使用与更持久的相关。
使用阿片类药物;感染艾滋病毒的风险较高;家庭、医疗、法律和职业问题较多;
致命过量服用的风险较高,应急管理(CM)是兴奋剂最有效的干预措施。
是阿片类药物使用障碍 (MOUD) 药物的循证辅助药物。
提供 MOUD 的阿片类药物治疗计划 (OTP) 仍然很低:事实上,获得 CM 是有争议的之一
成瘾治疗服务领域最大的研究与实践差距 C-DIAS 研究的目标。
项目2是进行III型混合有效性实施试验,以评估多层次的
实施战略,科学服务实验室(SSL),安装 CM 以在 OTP 中使用兴奋剂。
SSL 具有三个核心组成部分:教学培训;绩效反馈;以及项目。
采用通用的 C-DIAS 框架、措施和方法来指导 SSL 评估。
楔形设计中,由 10 个公共部门 OTP 组成的区域队列将被随机分配,以在五个不同的地点接受 SSL
每隔六个时间点,10 个 OTP 中的每一个都将提供 CM 上所有可用患者图表的数据。
每个 OTP 还将招募每个楔形 10 名患者(n = 500 名患者)来完成。
基线访谈和 3 个月的随访 此外,每个 OTP 的工作人员将报告相关情况。
本研究将严格评估三个时间点实施结果的决定因素。
由历史最悠久的国家中介供应商之一制定的多层次实施策略
组织——SAMHSA 技术转移中心,将改善实施和耐心
实施结果以 RE-AIM 为指导,包括 CM 覆盖、采用、实施。
和维持,而患者结果包括 CM 有效性的测量,例如兴奋剂戒断
该研究将通过揭开 C-DIAS 的黑匣子来推进 C-DIAS 的科学目标。
实施策略并探索环境的中介和调节影响
该研究项目侧重于积极的实施阶段,利用了双-
与 C-DIAS 的定向协同关系包括: 1) 标准化。
战略实施背景、结果和程序细节的衡量标准;2) PI (Becker) 在以下方面的作用:
C-DIAS 研究核心 3) 关键项目之间密切的合作和指导网络;
人员和 C-DIAS PI;以及 4) 可用于 C-DIAS 研究建模的数据的协调
核心专家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara J. Becker其他文献
Evaluation of sex disparities in opioid use among ED patients with sickle cell disease, 2006-2015.
2006-2015 年镰状细胞病 ED 患者阿片类药物使用性别差异的评估。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:3.6
- 作者:
T. Wilson;Shih;Sara J. Becker;J. Schuur;F. Beaudoin - 通讯作者:
F. Beaudoin
Brief Behavioral Interventions for Substance Use in Adolescents: A Meta-analysis
针对青少年药物滥用的简要行为干预:荟萃分析
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:8
- 作者:
D. Steele;Sara J. Becker;Kristin J. Danko;E. Balk;G. Adam;I. Saldanha;T. Trikalinos - 通讯作者:
T. Trikalinos
Evaluating approaches to marketing cognitive behavioral therapy: does evidence matter to consumers?
评估认知行为疗法的营销方法:证据对消费者重要吗?
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:4.7
- 作者:
C. Schofield;Gabriella T. Ponzini;Sara J. Becker - 通讯作者:
Sara J. Becker
Interventions for Substance Use Disorders in Adolescents: A Systematic Review
青少年药物使用障碍的干预措施:系统评价
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
D. Steele;Sara J. Becker;Kristin J. Danko;E. Balk;I. Saldanha;G. Adam;S. Bagley;C. Friedman;A. Spirito;Kelli Scott;E. Ntzani;Imani Saeed;Bryant T. Smith;J. Popp;T. Trikalinos - 通讯作者:
T. Trikalinos
Randomized Clinical Trials in Behavioral Medicine
行为医学随机临床试验
- DOI:
10.1007/978-0-387-93826-4_5 - 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
K. Freedland;Sara J. Becker;J. Blumenthal - 通讯作者:
J. Blumenthal
Sara J. Becker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara J. Becker', 18)}}的其他基金
HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
- 批准号:
10596437 - 财政年份:2022
- 资助金额:
$ 57.05万 - 项目类别:
HD2A RASC-SUD Implementation Support Core
HD2A RASC-SUD 实施支持核心
- 批准号:
10708983 - 财政年份:2022
- 资助金额:
$ 57.05万 - 项目类别:
C-DIAS RP 2: Implementing contingency management for stimulant use in specialty addiction treatment organizations
C-DIAS RP 2:在专业成瘾治疗组织中实施兴奋剂使用应急管理
- 批准号:
10668488 - 财政年份:2022
- 资助金额:
$ 57.05万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10665470 - 财政年份:2022
- 资助金额:
$ 57.05万 - 项目类别:
Improving Outcomes of Adolescents in Residential Substance use Treatment via a Technology-Assisted Parenting Intervention
通过技术辅助育儿干预改善青少年住宅药物滥用治疗的结果
- 批准号:
10666175 - 财政年份:2021
- 资助金额:
$ 57.05万 - 项目类别:
Neighborhood perceptions and response to a technology-assisted parenting intervention for youth substance use
社区对针对青少年药物滥用的技术辅助育儿干预的看法和反应
- 批准号:
10836689 - 财政年份:2021
- 资助金额:
$ 57.05万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10400426 - 财政年份:2018
- 资助金额:
$ 57.05万 - 项目类别:
Implementing contingency management in opioid treatment centers across New England: A hybrid type 3 trial
在新英格兰各地的阿片类药物治疗中心实施应急管理:一项混合 3 型试验
- 批准号:
10215461 - 财政年份:2018
- 资助金额:
$ 57.05万 - 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
- 批准号:
9034960 - 财政年份:2016
- 资助金额:
$ 57.05万 - 项目类别:
Adolescents with Substance Use Disorders Transitioning from Residential Treatment to the Community: Improving Outcomes via a Computer Assisted Parenting Program
患有药物滥用障碍的青少年从住院治疗过渡到社区:通过计算机辅助育儿计划改善治疗结果
- 批准号:
9263967 - 财政年份:2016
- 资助金额:
$ 57.05万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Efficacy and implementation of exercise-based smoking cessation treatment for adults with high anxiety sensitivity
以运动为基础的戒烟治疗对高焦虑敏感性成人的疗效和实施
- 批准号:
10660767 - 财政年份:2023
- 资助金额:
$ 57.05万 - 项目类别:
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
$ 57.05万 - 项目类别:
Veteran Social Support Intervention for Enhancing Smoking Treatment Utilization and Cessation
提高吸烟治疗利用率和戒烟的退伍军人社会支持干预
- 批准号:
10538304 - 财政年份:2023
- 资助金额:
$ 57.05万 - 项目类别:
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
促进青春期恢复生长的综合治疗 (InTEGRA)
- 批准号:
10680616 - 财政年份:2023
- 资助金额:
$ 57.05万 - 项目类别:
Women focused Encounters for Resilience, Independence, Strength and Eudaimonia (WE RISE)
以女性为中心的韧性、独立、力量和幸福的邂逅 (WE RISE)
- 批准号:
10744678 - 财政年份:2023
- 资助金额:
$ 57.05万 - 项目类别: